These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10759266)

  • 21. Management of Kell isoimmunization--evaluation of a Doppler-guided approach.
    Rimon E; Peltz R; Gamzu R; Yagel S; Feldman B; Chayen B; Achiron R; Lipitz S
    Ultrasound Obstet Gynecol; 2006 Nov; 28(6):814-20. PubMed ID: 16941575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kell sensitization in pregnancy.
    Caine ME; Mueller-Heubach E
    Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD; Gordon MC; Higby K
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit.
    Simms RA; Liebling RE; Patel RR; Denbow ML; Abdel-Fattah SA; Soothill PW; Overton TG
    Fetal Diagn Ther; 2009; 25(4):373-8. PubMed ID: 19786782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
    Lindenburg IT; van Kamp IL; van Zwet EW; Middeldorp JM; Klumper FJ; Oepkes D
    BJOG; 2013 Jun; 120(7):847-52. PubMed ID: 23551577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An audit of outcome in intravascular transfusions using the intrahepatic portion of the fetal umbilical vein compared to cordocentesis.
    Somerset DA; Moore A; Whittle MJ; Martin W; Kilby MD
    Fetal Diagn Ther; 2006; 21(3):272-6. PubMed ID: 16601337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome.
    Howard RJ; Tuck SM; Pearson TC
    Br J Obstet Gynaecol; 1995 Dec; 102(12):947-51. PubMed ID: 8652484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kell immunization--a case report].
    Tasić M; Milosević J; Stefanović M; Radović-Janosević D; Krstić M; Antić V
    Med Pregl; 2009; 62(7-8):369-72. PubMed ID: 19902791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic and therapeutic proceedings in pregnancies with blood group incompatibility: A retrospective analysis over 30 years].
    Müller T; Hofmann J; Kristen P; Dietl J
    Z Geburtshilfe Neonatol; 2002; 206(5):182-6. PubMed ID: 12395291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
    Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
    N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blueberry muffin rash, hyperbilirubinemia, and hypoglycemia: a case of hemolytic disease of the fetus and newborn due to anti-Kp(a).
    Brumbaugh JE; Morgan S; Beck JC; Zantek N; Kearney S; Bendel CM; Roberts KD
    J Perinatol; 2011 May; 31(5):373-6. PubMed ID: 21525882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hydrops fetalis caused by isoimmunization against Kell factor (author's transl)].
    Mattern H; Seifert H
    Klin Padiatr; 1980 Sep; 192(5):485-7. PubMed ID: 7192346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Perinatal research on feto-maternal anti-Kell immunization].
    Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat.
    Zimmerman R; Carpenter RJ; Durig P; Mari G
    BJOG; 2002 Jul; 109(7):746-52. PubMed ID: 12135209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term outcomes following intrauterine transfusions for fetal anaemia: A retrospective cohort study.
    Urutherakumar V; Welsh A; Henry A
    Aust N Z J Obstet Gynaecol; 2020 Oct; 60(5):738-745. PubMed ID: 32285444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Derivated fetal haemoglobin as a marker for red cell age in the human fetus reflecting stimulated or impaired red blood cell production.
    Huisman M; Egberts J; van Loon J
    Prenat Diagn; 2001 Jul; 21(7):523-8. PubMed ID: 11494284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.